Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P69
Within normal range
vs 2Y Ago
58x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 19.59% |
| Q2 2025 | -4.92% |
| Q1 2025 | 20.84% |
| Q4 2024 | 0.44% |
| Q3 2024 | -77.06% |
| Q2 2024 | 21.69% |
| Q1 2024 | -18.96% |
| Q4 2023 | 4.70% |
| Q3 2023 | 0.34% |
| Q2 2023 | 22.04% |
| Q1 2023 | -22.15% |
| Q4 2022 | 25.54% |
| Q3 2022 | -7.89% |
| Q2 2022 | -19.68% |
| Q1 2022 | 11.26% |
| Q4 2021 | 32.18% |
| Q3 2021 | -20824.56% |
| Q2 2021 | 100.90% |
| Q1 2021 | -47.79% |
| Q4 2020 | 7.58% |
| Q3 2020 | -2148.67% |
| Q2 2020 | 102.18% |
| Q1 2020 | 11.43% |
| Q4 2019 | -38.84% |
| Q3 2019 | 22.10% |
| Q2 2019 | -2.16% |
| Q1 2019 | -384.30% |
| Q4 2018 | 71.08% |
| Q3 2018 | -56.91% |
| Q2 2018 | 45.01% |
| Q1 2018 | -9.53% |
| Q4 2017 | 22.27% |
| Q3 2017 | 14.86% |
| Q2 2017 | 20.60% |
| Q1 2017 | 7.57% |
| Q4 2016 | -5.75% |
| Q3 2016 | 4.90% |
| Q2 2016 | -4.04% |
| Q1 2016 | -10.93% |
| Q4 2015 | -3.85% |